News Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Real-time Estimate Cboe BZX Other stock markets 20:38:06 30/04/2024 BST			5-day change	1st Jan Change
3.035 ^USD	-9.13%		-4.06%	-4.66%

01:31pm	B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	MT
04-29	HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	12:31pm	MT
HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	04-29	MT
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04-04	GL
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus Post Grant Review	03-28	AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-08	CI
Ovid Therapeutics : Corporate Presentation	03-08	PU
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562	03-08	MT
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	03-08	GL
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	03-08	AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-08	CI
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	02-28	GL
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	02-28	AQ
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	02-06	GL
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	02-06	AQ
BTIG Initiates Ovid Therapeutics With Buy Rating, Price Target is $11	12-21	MT
Ovid Therapeutics Inc.(NasdaqGS:OVID) added to NASDAQ Biotechnology Index	12-18	CI
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting	12-04	AQ
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	12-01	GL
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	12-01	AQ
Ovid Therapeutics : Corporate Presentation	11-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Summary

Filters